Cyclin-dependent kinase (CDK) activity as a prognostic marker in primary epithelial ovarian cancer

被引：0
|
作者：
de Souza, J. A.
Wei, C.
Noguchi, S.
Lu, K.
Ishihara, H.
Aoki, D.
Ueno, N. T.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Osaka Univ, Osaka, Japan
[3] Sysmex, Kobe, Hyogo, Japan
[4] Keio Univ, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5575
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in ovarian cancer
    Wang, Jinglu
    Dean, Dylan C.
    Hornicek, Francis J.
    Shi, Huirong
    Duan, Zhenfeng
    FASEB JOURNAL, 2019, 33 (05): : 5990 - 6000
  • [2] Cyclin-dependent kinase 9 (CDK9) predicts recurrence in Middle Eastern epithelial ovarian cancer
    Parvathareddy, Sandeep Kumar
    Siraj, Abdul K.
    Masoodi, Tariq
    Annaiyappanaidu, Padmanaban
    Al-Badawi, Ismail A.
    Al-Dayel, Fouad
    Al-Kuraya, Khawla S.
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [3] Cyclin-dependent kinase 9 (CDK9) predicts recurrence in Middle Eastern epithelial ovarian cancer
    Sandeep Kumar Parvathareddy
    Abdul K. Siraj
    Tariq Masoodi
    Padmanaban Annaiyappanaidu
    Ismail A. Al-Badawi
    Fouad Al-Dayel
    Khawla S. Al-Kuraya
    Journal of Ovarian Research, 14
  • [4] Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors
    Gitig, DM
    Koff, A
    MOLECULAR BIOTECHNOLOGY, 2001, 19 (02) : 179 - 188
  • [5] Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors
    Diana M. Gitig
    Andrew Koff
    Molecular Biotechnology, 2001, 19 : 179 - 188
  • [6] Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma
    Ma, Hangzhan
    Seebacher, Nicole A.
    Hornicek, Francis J.
    Duan, Zhenfeng
    EBIOMEDICINE, 2019, 39 : 182 - 193
  • [7] Changes in the activity of cyclin-dependent kinase 2 and cyclin-dependent kinase 5 accompany differentiation of rat primary oligodendrocytes
    Tang, XM
    Cambi, F
    Strocchi, P
    MOLECULAR BIOLOGY OF THE CELL, 1997, 8 : 120 - 120
  • [8] Cyclin-dependent kinase 1 and 2 activity as prognostic markers in early breast cancer
    van Nes, J. G. H.
    Smit, V. T. H. B. M.
    Putter, H.
    Kuppen, P. J.
    Kim, S. J.
    Masuda, N.
    Inaji, H.
    Yoshidome, K.
    Tsujimoto, M.
    Akiyama, F.
    Tsukamoto, F.
    Ishihara, H.
    Noguchi, S.
    van de Velde, C. J. H.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S254 - S254
  • [9] Cyclin-dependent kinase 12 (CDK12) in chordoma: prognostic and therapeutic value
    Thanindratarn, Pichaya
    Dean, Dylan C.
    Feng, Wenlong
    Wei, Ran
    Nelson, Scott D.
    Hornicek, Francis J.
    Duan, Zhenfeng
    EUROPEAN SPINE JOURNAL, 2020, 29 (12) : 3214 - 3228
  • [10] Targets of the cyclin-dependent kinase Cdk1
    Jeffrey A. Ubersax
    Erika L. Woodbury
    Phuong N. Quang
    Maria Paraz
    Justin D. Blethrow
    Kavita Shah
    Kevan M. Shokat
    David O. Morgan
    Nature, 2003, 425 : 859 - 864
12345